Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Welsh

Showing results (521-530 of 524) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 524 results.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamidesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.
Journal of Cardiology|March 17, 2023
Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II programJames K Chow, Akshay Bagai, Mary K Tan, et al.
Gigascience|April 5, 2016
Brainhack: a collaborative workshop for the open neuroscience communityR Cameron Craddock, Daniel S Margulies, Pierre Bellec, et al.
NEJM Evidence|November 10, 2025
Zalunfiban at First Medical Contact for ST-Elevation Myocardial InfarctionA W J Van't Hof, C M Gibson, S A O F Rikken, et al.
Pageof 53

Showing results (521-530 of 524) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 524 results.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamidesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.
Journal of Cardiology|March 17, 2023
Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II programJames K Chow, Akshay Bagai, Mary K Tan, et al.
Gigascience|April 5, 2016
Brainhack: a collaborative workshop for the open neuroscience communityR Cameron Craddock, Daniel S Margulies, Pierre Bellec, et al.
NEJM Evidence|November 10, 2025
Zalunfiban at First Medical Contact for ST-Elevation Myocardial InfarctionA W J Van't Hof, C M Gibson, S A O F Rikken, et al.
Pageof 53